Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Aoki

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Scientific Reports|August 29, 2025
Car4-positive adipocyte progenitor cells adapt to the aging environment and work as protection against ROS via glutathione metabolismMasato Horino, Kenji Ikeda, Rei Okazaki, et al.
Bone Marrow Transplantation|June 2, 2019
Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remissionShingo Yano, Hiroki Yokoyama, Masamitsu Yanada, et al.
Cardiovascular Diabetology|November 11, 2025
Artificial intelligence identifies individuals with prediabetes using single-lead electrocardiogramsDaisuke Koga, Ryo Kaneda, Chikara Komiya, et al.
Hematology (Amsterdam, Netherlands)|May 27, 2022
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantationHaruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, et al.
International Journal of Hematology|February 22, 2023
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantationKayoko Tao, Yoshihiro Inamoto, Haruhi Furukawa, et al.
Annals of Hematology|June 17, 2019
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemiaMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Transplantation and Cellular Therapy|April 8, 2021
Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell TransplantationNorihiro Ueda, Takaaki Konuma, Jun Aoki, et al.
Bone Marrow Transplantation|February 6, 2019
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantationHidehiro Itonaga, Ken Ishiyama, Kazunari Aoki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2019
Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell TransplantationKaito Harada, Takaaki Konuma, Shinichiro Machida, et al.
International Journal of Hematology|January 27, 2023
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three casesTakanori Fukuta, Takashi Tanaka, Taiki Hashimoto, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Scientific Reports|August 29, 2025
Car4-positive adipocyte progenitor cells adapt to the aging environment and work as protection against ROS via glutathione metabolismMasato Horino, Kenji Ikeda, Rei Okazaki, et al.
Bone Marrow Transplantation|June 2, 2019
Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remissionShingo Yano, Hiroki Yokoyama, Masamitsu Yanada, et al.
Cardiovascular Diabetology|November 11, 2025
Artificial intelligence identifies individuals with prediabetes using single-lead electrocardiogramsDaisuke Koga, Ryo Kaneda, Chikara Komiya, et al.
Hematology (Amsterdam, Netherlands)|May 27, 2022
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantationHaruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, et al.
International Journal of Hematology|February 22, 2023
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantationKayoko Tao, Yoshihiro Inamoto, Haruhi Furukawa, et al.
Annals of Hematology|June 17, 2019
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemiaMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Transplantation and Cellular Therapy|April 8, 2021
Prognostic Impact of the Fractionation of Total Body Irradiation for Patients with Acute Myeloid Leukemia Undergoing Myeloablative Allogeneic Hematopoietic Cell TransplantationNorihiro Ueda, Takaaki Konuma, Jun Aoki, et al.
Bone Marrow Transplantation|February 6, 2019
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantationHidehiro Itonaga, Ken Ishiyama, Kazunari Aoki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2019
Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell TransplantationKaito Harada, Takaaki Konuma, Shinichiro Machida, et al.
International Journal of Hematology|January 27, 2023
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three casesTakanori Fukuta, Takashi Tanaka, Taiki Hashimoto, et al.
Pageof 15